Company intelligence / Profile preview

Glimpse Diagnostics

Minneapolis, Minnesota, United States

Ownership: Private
Development stage: Other

Overview

Glimpse Diagnostics has developed an AI-powered ear infection diagnostic platform combining a proprietary pediatric otoscope speculum with artificial intelligence technology that provides image classification results in under one minute with 92.5% accuracy[2]. The platform is designed for at-home telemedicine use and clinical applications to streamline pediatric ear infection diagnosis.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Medical Imaging

Partnerships

Diversified Plastics Inc.

Beyond the preview

Go deeper on Glimpse Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glimpse Diagnostics.

Explore the full profile